Wells Fargo’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6K Hold
450
– – ﹤0.01% 5982
2026
Q1
$12.7K Hold
450
– – ﹤0.01% 5909
2025
Q4
$12.5K Buy
+450
New +$10.8K ﹤0.01% 5903
2025
Q3
– Sell
-1,000
Closed -$17.6K – 7313
2025
Q2
$17.6K Buy
1,000
+50
+5% +$806 ﹤0.01% 5818
2025
Q1
$14.9K Buy
950
+150
+19% +$2.53K ﹤0.01% 5789
2024
Q4
$15.3K Hold
800
– – ﹤0.01% 5825
2024
Q3
$14.8K Buy
800
+100
+14% +$1.83K ﹤0.01% 5708
2024
Q2
$13.2K Buy
+700
New +$14.2K ﹤0.01% 5694

Other funds holding PHVS

Wells Fargo's PHVS Position: Q2 2026 in Review

Wells Fargo held its Pharvaris (PHVS) position steady in Q2 2026 at 450 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5982.

Wells Fargo first reported a position in PHVS in Q2 2024 and has held it in 8 quarters since. The position peaked at $17.6K in Q2 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Wells Fargo held 450 shares of Pharvaris worth $15.6K as of Q2 2026.
  • Wells Fargo left its Pharvaris share count unchanged in Q2 2026.
  • Pharvaris made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5982 holding.
  • Wells Fargo first reported a position in Pharvaris in Q2 2024 and has held it in 8 quarters since.
  • Wells Fargo's Pharvaris position peaked at $17.6K in Q2 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.